Clinical implications of HIV-1 drug resistance in the neurological compartment

References

• Bacellar H, Munoz A, Miller EN, Cohen BA, Besley D, Selnes OA, et al. Temporal trends in the incidence of HIV-1 related neurologic diseases: multicenter AIDS Cohort Study, 1985–1992. Neurology 1994; 44: 1892–900.
   PubMed Web of Science ®Google Scholar
• Brew BJ, Pemberton L, Cunningham P, Law MG. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J Infect Dis 1997; 175: 963–6.
   PubMed Web of Science ®Google Scholar
• McArthur JC, McClernon DR, Cronin MF, Nance-Sproson TE, Saah AJ, St Clair M, Lanier ER. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Ann Neurol 1997; 42: 689–98.
   Google Scholar
• Cinque P, Vago L, Ceresa D, Mainini F, Terreni MR, Vagani A, et al. Cerebrospinal fluid HIV-1 RNA levels: correlation with HIV encephalitis. AIDS 1998; 12: 389–94.
   PubMed Web of Science ®Google Scholar
• Sheehy N, Desselberger U, Whitewell H, Ball JK. Concurrent evolution of regions of the envelope and polymerase genes of human immunodeficiency virus type 1 observed during zidovudine (AZT) therapy. J Gen Virol 1996; 77: 1071–81.
   PubMed Web of Science ®Google Scholar
• Brew BJ, Evans L, Byrne C, Pemberton L, Hurren L. The relationship between AIDS dementia complex and the presence of macrophage tropic and non-syncitium inducing isolates of human immunedeficiency virus type 1 in the cerebrospinal fluid. J Neurovirol 1996; 2: 152–7.
   Google Scholar
• Di Stefano M, Monno L, Fiore JR, Angarano G. In-vivo evidence of HIV-1 productive infection in cerebrospinal fluid of patients with HIV-1 encephalitis. AIDS 1997; 11: 133–5.
   PubMed Web of Science ®Google Scholar
• Haas DW, Clough LA, Johnson BW, Harris VL, Spearman P, Wilkinson GR, et al. Evidence of a source of HIV type 1 within the central nervous system by ultraintensive sampling of cerebrospinal fluid and plasma. AIDS Res Hum Retroviruses 2000; 16: 1491–502.
   PubMed Web of Science ®Google Scholar
• Chiodi F, Keys B, Albert J, Hagberg L, Lundeberg J, Uhlen M, et al. Human immunodeficiency virus type 1 is present in the cerebrospinal fluid of a majority of infected individuals. J Clin Microbiol 1992; 30: 1768–71.
   PubMed Web of Science ®Google Scholar
• Tambussi G, Gori A, Capiluppi B, Balotta C, Papagno L, Morandini B, et al. Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid. Clin Infect Dis 2000; 30: 962–5.
   PubMed Web of Science ®Google Scholar
• Garcia F, Niebla G, Romeu J, Vidal C, Plana M, Ortega M, et al. Cerebrospinal fluid HIV-1 RNA levels in asymptomatic patients with early stage chronic HIV-1 infection: support forthe hypothesis of local virus replication. AIDS 1999; 13: 1491–6.
   PubMed Web of Science ®Google Scholar
• Staprans S, Marlowe N, Glidden D, Novakovic-Agopian T, Grant RM, Heyes M, et al. Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection. AIDS 1999; 13: 1051–61.
   Google Scholar
• Ellis R, Hsia K, Spector S, Nelson JA, Heaton RK, Wallace MR, et al. CSF HIV-1 RNA levels are elevated in neurocognitively impaired individuals. Ann Neurol 1997; 42: 679–88.
   PubMed Web of Science ®Google Scholar
• Ellis RJ, Gamst AC, Capparelli E, Spector SA, Hsia K, Wolfson T, et al. Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources. Neurology 2000; 54: 927–36.
   PubMed Web of Science ®Google Scholar
• De Luca A, Ciancio BC, Larussa D, Murri R, Cingolani A, Rizzo MG, et al. Correlates of independent HIV-1 replication in the CNS and of its control by antiretrovirals. Neurology 2002; 59: 342–7.
   PubMed Web of Science ®Google Scholar
• Antinori A, Giancola ML, Grisetti S, Soldani F, Alba L, Liuzzi G, et al. Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1 infected patients. AIDS 2002; 16: 1867–76.
   PubMed Web of Science ®Google Scholar
• De Luca A, Giancola ML, Ammassari A, Grisetti S, Paglia MG, Gentile M, et al. The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy. J Infect Dis 2000; 182: 1077–83.
   PubMed Web of Science ®Google Scholar
• Clifford DB. Human immunodeficiency virus-associated dementia. Arch Neurol 2000; 57: 321–4.
   PubMedGoogle Scholar
• Foudraine NA, Hoetelmans RM, Lange JM, de Wolf F, van Benthem BHB, Maas JJ, et al. Cerebrospinal fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine. Lancet 1998; 351: 1547–51.
   Google Scholar
• Martin C, Sonnerborg A, Svensson JO, Stahle L. Indinavirbased treatment of HIV-1 infected patients: efficacy in the central nervous system. AIDS 1999; 13: 1227–32.
   PubMed Web of Science ®Google Scholar
• Antinori A, Perno CF, Giancola ML, Forbici F, Ippolito G, Hoetelmans R, Piscitelli SC. Antiretroviral distribution in cerebrospinal fluid and viral resistance in HIV-infected patients. 9th Conference of Retrovirus and Opportunistic Infection, Seattle, USA, 24–28 February 2002. Abstract 438–W
   Google Scholar
• van Praag RME, Weverling GJ, Portegies P, Jurriaans S, Zhou XJ, Turner-Foisy ML, et al. Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir. AIDS 2000; 14: 1187–94.
   Google Scholar
• Gisolf EH, Enting RH, Jurriaans S, de Wolf F, van der Ende ME, Hoetelmans RMW, et al. Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir saquinavir or ritonavir saquinavir stavudine. AIDS 2000; 14: 1583–9.
   Google Scholar
• Kravcik S, Gallicano K, Roth V, Cassol S, Hawley-Foss N, Badley A, Cameron DW. Cerebrospinal fluid HIV RNA and drug levels with combination ritonavir and saquinavir. J Acquir Immune Defic Syndr 1999; 21: 371–5.
   Google Scholar
• Aweeka F, Jayewardene A, Staprans S, Bellibas SE, Kearney B, Lizak P, et al. Failure to detect nelfinavir in the cerebrospinal fluid of HIV-1 infected patients with and without AIDS dementia complex. J Acquir Immune Defic Syndr 1999; 20: 39–43.
   Web of Science ®Google Scholar
• Gisolf EH, van Praag RME, Jurrians S, Portegies P, Goudsmit J, Danner SA, et al. Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1 infected patients receiving antiretroviral therapy. J Acquir Immune Defic Syndr 2000; 25: 426–33.
   PubMed Web of Science ®Google Scholar
• Cunningham PH, Smith DG, Satchell C, Cooper DA, Brew B. Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid. AIDS 2000; 14: 1949–54.
   Google Scholar
• Stingele K, Haas J, Zimmermann T, Stingele R, Hubsch-Muller C, Freitag M, et al. Independent HIV replication in paired CSF and blood viral isolates during antiretroviral therapy. Neurology 2001; 56: 255–361.
   Google Scholar
• Venturi G, Catucci M, Romano L, Corsi P, Leoncini F, Valensin PE, Zazzi M. Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples. J Infect Dis 2000; 181: 740–5.
   Google Scholar
• Lanier ER, Sturge G, McClernon D, Brown S, Halman M, Sacktor N, et al. HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with Abacavir. AIDS 2001; 15: 747–51.
   PubMed Web of Science ®Google Scholar
• Gunthard HF, Wong JK, Ignacio CC, Guatelli JC, Riggs NL, Havlir DV, Richman DD. Human immunodeficiency virus replication and genotypic resistance in blood and lymph nodes after a year of potent antiretroviral therapy. J Virol 1998; 72: 2422–8.
   Google Scholar
• Price RW, Paxinos EE, Grant RM, Drews B, Nilsson A, Hoh R, et al. Cerebrospinal fluid response to structured treatment interruption after virological failure. AIDS 2001; 15: 1251–9.
   PubMed Web of Science ®Google Scholar